<DOC>
	<DOC>NCT01542411</DOC>
	<brief_summary>This study evaluated the effect of anticoagulant treatment on the live-birth rate in women with a history of at least two continuous unexplained miscarriages or thrombophilia. It also compared two methods of treatment with aspirin and aspirin plus heparin.</brief_summary>
	<brief_title>Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Spontaneous</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>unexplained recurrent miscarriage, women had previous venous or arterial thromboembolism or who were heterozygous or homozygous for mutations for FV Leiden G1691A, prothrombin gene G20210A (FII G20210A), and methyltetrahydrofolate reductase C677T (MTHFR C677T) abnormal karyotypes of both partners, uterine and cervical anatomical disorders on pelvic ultrasonography or hysteroscopy, abnormal ovaries and abnormal endocrine tests.</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>